Simões, PBMateus, SBrazão, HSalvado, C2023-08-102023-08-102022Rev Port Diabetes. 2022; 17 (1): 23-25http://hdl.handle.net/10400.17/4634We present a case of cellulitis complicating with abscess formation as a possible complication of treatment with injectable GLP-1 agonists on a sixty-one-year-old woman. Pus cultures showed isolation of Streptococcus anginosus and clindamycin was started as targeted therapy but absence of improvement prompted a consultation with the surgery department and a manual surgical debridement was performed. A second isolate of Eikenella corrodens, which is frequently resistant to clindamycin, was identified. We opted for a switch to ceftriaxone and after nineteen days, having achieved clinical improvement, plans were made for her to continue to change her wound dressing at her local health center and for a short-term revaluation at a surgery outpatient consultation. Caring for social needs and assuring continuity across multiple care levels can be fundamental in preventing adverse effects from self-injectable drugs.engCellulitisGLP-1 agonistAbscessObesitySocial needsCase ReportHSAC MEDjournal article